We are live on ! Find out more
INVA icon

Innoviva

201 hedge funds and large institutions have $778M invested in Innoviva in 2019 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 65 increasing their positions, 81 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more call options, than puts

Call options by funds: $14M | Put options by funds: $5.85M

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

3.94% less ownership

Funds ownership: 76.83%72.89% (-3.9%)

7% less funds holding

Funds holding: 217201 (-16)

20% less repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 81

31% less capital invested

Capital invested by funds: $1.13B → $778M (-$355M)

47% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 34

Holders
201
Holders Change
-16
Holders Change %
-7.37%
% of All Funds
4.41%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
18
Increased
65
Reduced
81
Closed
34
Calls
$14M
Puts
$5.85M
Net Calls
+$8.17M
Net Calls Change
-$6.2M
Name Holding Trade Value Shares
Change
Change in
Stake
N
26
Nuveen
North Carolina
$6.06M +$27K +2,259 +0.4%
Schroder Investment Management Group
27
Schroder Investment Management Group
United Kingdom
$5.85M -$2.07M -173,053 -23%
CEP
28
Chicago Equity Partners
Illinois
$4.95M -$190K -15,890 -3%
Millennium Management
29
Millennium Management
New York
$4.45M +$4.78M +399,551 +1,759%
JIM
30
Jupiter Investment Management
United Kingdom
$4.4M -$406K -33,916 -8%
Charles Schwab
31
Charles Schwab
California
$4.18M +$85.6K +7,155 +2%
1M
32
13D Management
New York
$4.14M +$214K +17,899 +5%
Arrowstreet Capital
33
Arrowstreet Capital
Massachusetts
$4.05M -$4.93M -412,215 -52%
AC
34
Antara Capital
New York
$3.99M -$5.02M -419,476 -53%
Assenagon Asset Management
35
Assenagon Asset Management
Luxembourg
$3.98M +$4.52M +377,613 New
Wells Fargo
36
Wells Fargo
California
$3.79M -$18.4M -1,539,734 -81%
Ameriprise
37
Ameriprise
Minnesota
$3.74M -$527K -44,035 -11%
Morgan Stanley
38
Morgan Stanley
New York
$3.55M -$2.15M -179,532 -35%
Goldman Sachs
39
Goldman Sachs
New York
$2.63M -$2.83M -237,072 -49%
Prudential Financial
40
Prudential Financial
New Jersey
$2.6M +$1.25M +104,319 +73%
AllianceBernstein
41
AllianceBernstein
Tennessee
$2.58M -$187K -15,600 -6%
AQR Capital Management
42
AQR Capital Management
Connecticut
$2.56M +$1.19M +99,171 +69%
CM
43
Caption Management
Oklahoma
$2.55M +$2.89M +242,000 New
SG Americas Securities
44
SG Americas Securities
New York
$2.52M +$701K +58,658 +32%
Baird Financial Group
45
Baird Financial Group
Wisconsin
$2.44M +$51.1K +4,270 +2%
Acadian Asset Management
46
Acadian Asset Management
Massachusetts
$2.42M -$1.14M -95,168 -29%
PPA
47
Parametric Portfolio Associates
Washington
$2.34M -$656K -54,892 -20%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$2.17M +$42.4K +3,547 +2%
American Century Companies
49
American Century Companies
Missouri
$2.17M -$1.08M -90,333 -31%
Jane Street
50
Jane Street
New York
$2.15M +$2.44M +204,326 New

INVA Hedge Fund Activity: Q3 2019 in Review

201 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q3 2019, worth a combined $778M — down 31% from $1.13B a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of INVA and 18 opened new positions — a net loss of 16 holders — while 81 trimmed existing stakes and 65 added.

The largest buyer was Atom Investors, adding an estimated $6.94M. The largest seller was Wells Fargo, cutting an estimated $18.4M.

  • 201 institutional investors held Innoviva (INVA) as of Q3 2019, down from 217 in Q2 2019.
  • Funds reported $778M of Innoviva stock for Q3 2019, down 31% quarter-over-quarter.
  • 18 funds opened new Innoviva positions in Q3 2019 and 34 closed out, a net change of -16 holders.
  • The largest Innoviva buyer in Q3 2019 was Atom Investors, an estimated $6.94M added.
  • The largest Innoviva seller in Q3 2019 was Wells Fargo, an estimated $18.4M sold.

Based on aggregated 13F filings for Q3 2019.